1192. Correlation Between SARS CoV 2 Viral Load and Clinical Evolution of Patients Under 15 Years of Age with COVID 19 in a General Hospital in the Province of Buenos Aires, Argent...

por Brizuela, Martin, Goñi, Sandra, Cardama, Georgina, Sommese, Leandro, Farina, Hernan
Publicado 2021

Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma

por Trebucq, Laura Lucía, Cardama, Georgina Alexandra, Lorenzano Menna, Pablo, Golombek, Diego Andrés, Chiesa, Juan José, Marpegan, Luciano
Publicado 2021

Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines

por Cabrera, Maia, Echeverria, Emiliana, Lenicov, Federico Remes, Cardama, Georgina, Gonzalez, Nazareno, Davio, Carlos, Fernández, Natalia, Menna, Pablo Lorenzano
Publicado 2017

Correlation of SARS-CoV-2 Viral Load and Clinical Evolution of Pediatric Patients in a General Hospital From Buenos Aires, Argentina

por Brizuela, Martín Eduardo, Goñi, Sandra Elizabeth, Cardama, Georgina Alexandra, Zinni, María Alejandra, Castello, Alejandro Andres, Sommese, Leandro Matías, Farina, Hernán Gabriel
Publicado 2022

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

por Cardama, Georgina A, Gonzalez, Nazareno, Ciarlantini, Matias, Gandolfi Donadío, Lucia, Comin, María Julieta, Alonso, Daniel F, Menna, Pablo Lorenzano, Gomez, Daniel E
Publicado 2014

Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines

por Cardama, Georgina A, Comin, Maria J, Hornos, Leandro, Gonzalez, Nazareno, Defelipe, Lucas, Turjanski, Adrian G, Alonso, Daniel F, Gomez, Daniel E, Menna, Pablo Lorenzano
Publicado 2014

Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity

por González, Nazareno, Cardama, Georgina A., Chinestrad, Patricio, Robles-Valero, Javier, Rodríguez-Fdez, Sonia, Lorenzo-Martín, L. Francisco, Bustelo, Xosé R., Lorenzano Menna, Pablo, Gomez, Daniel E.
Publicado 2020

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma

por Cardama, Georgina A., Bucci, Paula L., Lemos, Jesús S., Llavona, Candela, Benavente, Micaela A., Hellmén, Eva, Fara, María Laura, Medrano, Eduardo, Spitzer, Eduardo, Demarco, Ignacio A., Sabella, Patricia, Garona, Juan, Alonso, Daniel F.
Publicado 2023

Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models

por Cardama, Georgina A., Maggio, Julian, Valdez Capuccino, Lucas, Gonzalez, Nazareno, Matiller, Valentina, Ortega, Hugo H., Perez, German R., Demarco, Ignacio A., Spitzer, Eduardo, Gomez, Daniel E., Lorenzano Menna, Pablo, Alonso, Daniel F.
Publicado 2022

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial

por Krolewiecki, Alejandro, Lifschitz, Adrián, Moragas, Matías, Travacio, Marina, Valentini, Ricardo, Alonso, Daniel F., Solari, Rubén, Tinelli, Marcelo A., Cimino, Rubén O., Álvarez, Luis, Fleitas, Pedro E., Ceballos, Laura, Golemba, Marcelo, Fernández, Florencia, Fernández de Oliveira, Diego, Astudillo, German, Baeck, Inés, Farina, Javier, Cardama, Georgina A., Mangano, Andrea, Spitzer, Eduardo, Gold, Silvia, Lanusse, Carlos
Publicado 2021

Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]”

por Krolewiecki, Alejandro, Lifschitz, Adrián, Moragas, Matías, Travacio, Marina, Valentini, Ricardo, Alonso, Daniel F., Solari, Rubén, Tinelli, Marcelo A., Cimino, Rubén O., Álvarez, Luis, Fleitas, Pedro E., Ceballos, Laura, Golemba, Marcelo, Fernández, Florencia, de Oliveira, Diego Fernández, Astudillo, German, Baeck, Inés, Farina, Javier, Cardama, Georgina A., Mangano, Andrea, Spitzer, Eduardo, Gold, Silvia, Lanusse, Carlos
Publicado 2021